• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Erectile Dysfunction Drug Pipeline Capsule - 2012 Product Image

Global Erectile Dysfunction Drug Pipeline Capsule - 2012

  • Published: January 2012
  • Region: Global
  • 13 pages
  • Fore Pharma

Fore Pharma’s latest report ‘Global Erectile Dysfunction Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global erectile dysfunction drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies READ MORE >

1. Erectile Dysfunction: Disease Definition
2. Erectile Dysfunction Drug Pipeline Overview
3. Erectile Dysfunction Phase 3 Clinical Trial Drug Pipeline Insights
4. Erectile Dysfunction Phase 2 Clinical Trial Drug Pipeline Insights
5. Erectile Dysfunction Phase 1 Clinical Trial Drug Pipeline Insights
6. Erectile Dysfunction Preclinical Research Drug Pipeline Insights
7. Erectile Dysfunction Drug Discovery Pipeline Insights
8. Geographic Landscape of Erectile Dysfunction R&D Activities
8.1 Erectile Dysfunction R&D Activities in North America
8.2 Erectile Dysfunction R&D Activities in Europe
9 Licensing Activities / Partnerships in the Global Erectile Dysfunction Drug Market
10 Research Methodology
Table 1: Erectile Dysfunction Drug Pipeline: Phase 3 Clinical Trial
Table 2: Erectile Dysfunction Drug Pipeline: Phase 2 Clinical Trial
Table 3: Erectile Dysfunction Drug Pipeline: Phase 1 Molecules
Table 4: Erectile Dysfunction Drug Pipeline: Preclinical Research
Table 5: Erectile Dysfunction R&D Activities by Geography
Table 6: Erectile Dysfunction Drug Pipeline: North America
Table 7: Erectile Dysfunction Drug Pipeline: Europe
Table 8: Erectile Dysfunction Drug Pipeline: Licensing Activities
Figure 1 : Erectile Dysfunction Drug Pipeline Molecules by Stages
Figure 2 : Erectile Dysfunction R&D Activities by Geography

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos